Pochiraju Industries Ltd - Stock Valuation and Financial Performance

Name: Pochiraju Industries
Brand: Pochiraju Industries

BSE: 532803 | NSE: POCHIRAJU | Floriculture | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Pochiraju Industries

Based on:

Data

M-Cap below 100cr DeciZen not available

Pochiraju Industries stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

3.7 Cr.

52-wk low:

3.1

52-wk high:

3.4

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

The key valuation ratios of Pochiraju Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Pochiraju Industries:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	TTM
ROCE % ⓘ	11.6%	11.3%	5.7%	8.6%	3.2%	-29.7%	-29.5%	-7.1%	-4.6%	-5.1%	-
Value Creation Index ⓘ	-0.2	-0.2	-0.6	-0.4	-0.8	-3.1	-3.1	-1.5	-1.3	-1.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	55.4	72.4	109	120	139	9.7	0	0	0	0	0
Sales YoY Gr.	-	30.7%	50.3%	10%	16.2%	-93.1%	-100%	NA	NA	NA	-
Adj EPS ⓘ	6.2	7.9	2.8	5.5	0.6	-27.4	-20.2	-5.8	-2	-2.1	-2.1
YoY Gr.	-	26.8%	-65%	99.3%	-88.9%	-4588.5%	NA	NA	NA	NA	-
BVPS (₹) ⓘ	43.8	52.1	53.7	63.3	63.9	36.5	23.5	17.7	15.7	13.6	15.2
Adj Net Profit ⓘ	11.7	14.9	5.2	10.4	1.2	-51.8	-38.1	-11.1	-3.8	-4	-4
Cash Flow from Ops. ⓘ	11.7	13.3	7.5	2.6	45.9	-0.1	0	0	0	0	-
Debt/CF from Ops. ⓘ	1.1	2.2	4.1	15.4	1.1	-540.4	-10176.3	-77111.2	-97079.5	-2332241.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-100%	-100%	NA	NA
Adj EPS ⓘ	-188.8%	-228.4%	NA	NA
BVPSⓘ	-12.2%	-26.6%	-16.8%	-13.6%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	TTM
Return on Equity % ⓘ	12.3	13.4	4.3	8	0.9	-47.2	-58.9	-27.6	-11.5	-14	-14.7
Op. Profit Mgn % ⓘ	25.3	23	15.7	18.6	6.9	-412.8	0	0	0	0	NAN
Net Profit Mgn % ⓘ	21.1	20.5	4.8	8.7	0.8	-535.3	0	0	0	0	-INF
Debt to Equity ⓘ	0.2	0.3	0.3	0.3	0.4	0.7	1.1	1.5	1.6	1.9	-
Working Cap Days ⓘ	180	148	122	171	149	890	0	0	0	0	0
Cash Conv. Cycle ⓘ	144	118	100	132	100	525	0	0	0	0	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Pochiraju Industries Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-2.1	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	15.2	-
Reserves (₹ Cr.) ⓘ	10	-
P/BV ⓘ	0.13	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	3.10 / 3.43
All Time Low / High (₹)	2.65 / 88.10
Market Cap (₹ Cr.)	3.7
Equity (₹ Cr.)	18.9
Face Value (₹)	10
Industry PE ⓘ	75.9

Management X-Ray of Pochiraju Industries:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Pochiraju Industries

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Pochiraju Industries

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Sales	55.44	72.43	108.86	119.74	139.12	9.67	0	0	0	0
Operating Expenses ⓘ	41.40	55.75	91.82	97.50	129.59	49.60	16.93	0.64	0.16	0.34
Manufacturing Costs	3.21	6.47	15.41	6.84	19.78	3.16	0.01	0.07	0	0
Material Costs	34.36	43.74	65.07	81.31	93.01	12.57	0	0	0	0
Employee Cost	2.07	2.88	4.10	3.78	3.93	0.96	0.04	0.09	0.01	0
Other Costs ⓘ	1.76	2.65	7.23	5.56	12.86	32.91	16.88	0.48	0.15	0.34
Operating Profit ⓘ	14.04	16.69	17.04	22.24	9.54	-39.93	-16.93	-0.64	-0.16	-0.34
Operating Profit Margin (%)	25.3%	23.0%	15.7%	18.6%	6.9%	-412.0%	-	-	-	-
Other Income ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.24	0.10	4.84	5.42	6.67	6.80	6.80	6.80	0	0.07
Depreciation ⓘ	1.73	1.73	5.32	5.71	3.96	4.69	14.59	3.60	3.60	3.60
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	12.07	14.86	6.88	11.11	-1.10	-51.42	-38.32	-11.05	-3.76	-4.02
Tax ⓘ	0.35	0	1.67	0.74	-2.24	0.35	-0.22	0	0	0
Profit After Tax	11.72	14.86	5.21	10.37	1.15	-51.77	-38.11	-11.05	-3.76	-4.02
PAT Margin (%)	21.1%	20.5%	4.8%	8.7%	0.8%	-535.0%	-	-	-	-
Adjusted EPS (₹)	6.2	7.9	2.8	5.5	0.6	-27.4	-20.2	-5.8	-2.0	-2.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Equity and Liabilities
Shareholders Fund	101.31	117.68	122.89	133.26	134.38	82.61	44.50	33.46	29.69	25.67
Share Capital ⓘ	18.91	18.91	18.91	18.91	18.91	18.91	18.91	18.91	18.91	18.91
Reserves ⓘ	82.41	98.78	103.98	114.35	115.48	63.70	25.60	14.55	10.79	6.77
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	13.26	28.78	23.24	31.19	29.55	29.55	29.55	29.55	48.51	48.51
Long Term Debt	13.26	28.78	23.24	15.48	7.47	7.47	7.47	7.47	7.47	7.47
Short Term Debt	0	0	0	15.71	22.08	22.08	22.08	22.08	41.04	41.04
Trade Payables	0.49	0.23	0.27	0.25	0.55	0.51	0.86	1.50	0.47	0.47
Others Liabilities ⓘ	1.88	1.81	10.30	13.87	21.38	28.54	35.12	41.93	24.15	24.56
Total Liabilities ⓘ	116.95	148.51	156.69	178.57	185.86	141.20	110.03	106.43	102.82	99.22
Fixed Assets
Gross Block	19.04	87.52	87.52	87.52	98.64	98.64	94.41	94.41	94.41	94.41
Accumulated Depreciation	9.64	11.37	16.69	22.40	26.27	30.95	45.54	49.14	52.75	56.35
Net Fixed Assetsⓘ	9.40	76.15	70.83	65.12	72.37	67.68	48.87	45.27	41.66	38.06
CWIP ⓘ	58.15	21.19	21.75	29.54	56.34	56.34	60.56	60.56	60.56	60.56
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	7.46	6.95	10.59	21.74	10.39	0	0	0	0	0
Trade Receivables	15.40	18.03	24.75	30.15	14.88	3.04	0	0	0	0
Cash Equivalents	2.64	1.39	0.75	0.23	0.10	0.01	0	0	0	0
Others Assetsⓘ	23.90	24.80	28.02	31.79	31.79	14.13	0.59	0.59	0.59	0.59
Total Assets ⓘ	116.95	148.51	156.69	178.57	185.86	141.20	110.03	106.43	102.82	99.22

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Cash Flow From Operating Activity ⓘ	11.69	13.34	7.53	2.63	45.91	-0.09	0	0	0	0
PBT ⓘ	12.07	14.86	6.88	11.11	-1.10	-51.42	-38.32	-11.05	-3.76	-4.02
Adjustment ⓘ	1.92	1.79	10.12	11.09	10.59	11.49	28.13	3.60	3.60	3.60
Changes in Working Capital ⓘ	-1.76	-3.25	-4.68	-13.88	43.04	39.84	10.19	7.44	0.16	0.41
Tax Paid ⓘ	-0.35	0	0	-0.31	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	-24.67	-31.20	-2.61	-11.11	-38.04	0	0	0	0	0
Capex	-7.99	-31.52	-0.56	-11.11	-23.61	0	0	0	0	0
Net Investments	-2.36	0	-2.05	0	0	0	0	0	0	0
Others ⓘ	-14.32	0.32	0	0	-14.42	0	0	0	0	0
Cash Flow From Financing Activityⓘ	14.91	16.61	-5.55	7.95	-8.01	0	0	0	0	0
Net Proceeds from Shares ⓘ	3.55	1.08	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	11.36	15.53	-5.55	7.95	-8.01	0	0	0	0	0
Net Cash Flow ⓘ	1.94	-1.25	-0.63	-0.52	-0.13	-0.09	0	0	0	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Ratios
ROE (%)	15.09	16.39	5.21	9.37	0.95	-54.52	-67.1	-28.34	-11.92	-14.52
ROCE (%)	14.31	13.21	8.94	11.23	3.36	-30.86	-29.62	-4.79	-4.63	-5.11
Asset Turnover Ratio	0.54	0.55	0.71	0.71	0.76	0.06	0	0	0	0
PAT to CFO Conversion(x)	1	0.9	1.45	0.25	39.92	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	98	84	72	84	59	338	0	0	0	0
Inventory Days	49	36	29	49	42	0	0	0	0	0
Payable Days	4	3	1	1	2	15	0	0	0	0

Pochiraju Industries Ltd Stock News

Pochiraju Industries Ltd FAQs

What is the share price of Pochiraju Industries?

Company share prices are keep on changing according to the market conditions. The closing price of Pochiraju Industries on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Pochiraju Industries?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Pochiraju Industries stood at ₹3.69.

What is the P/E ratio of Pochiraju Industries?

The latest P/E ratio of Pochiraju Industries as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Pochiraju Industries?

The latest P/B ratio of Pochiraju Industries as of 01-Jan-1970 05:30 is 0.13.

What is the 52-week high and low of Pochiraju Industries?

The 52-week high of Pochiraju Industries is ₹3.43 and the 52-week low is ₹3.10.

What is the TTM revenue of Pochiraju Industries?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Pochiraju Industries is ₹0.00 ( Cr.) .

About Pochiraju Industries Ltd

The company was originally incorporated as Pochiraju Flori-Tech Limited on May 4, 1995 with Registrar of Companies Tamil Nadu, Chennai. The certificate for commencement of business was received on June 5, 1995. The name of the company was changed to Pochiraju Industries Ltd. and fresh certificate of incorporation was obtained on September 10, 2003 from Registrar of Companies, Coimbatore

The company is currently focusing on three business segments â€“ Agri Business, Pharmaceuticals and Bio-Technology & Life Sciences. The organizational structure of the company is designed for effective management of multiple business, while retaining focus on each one of them.

Pharmapil is the Pharma Division of PIL, operating its range of pharmaceutical formulations on a national level through aggressive, dynamic and committed field force of over 250 medical representatives. Pharmapil will have two divisions, the General and the Specialty divisions and market products in tablet, capsule, liquid, injectable, powder and ointment dosage forms.

Biopil is the Biotechnology Division of PIL. A state of art plant is under construction spread over 3.86 acres of land in the S. P. Biotechnology Park situated at Turkapally, Shamirpet, Hyderabad. This plant shall utilize cell fusion techniques, hybidomas recombinant DNA technology, protein engineering and structure based molecular design which are part of modern Biotechnology. The product range shall include biosimilar products, such as Erythropoietin, G-CSF, Interferon Alpha, Interferon Beta, Human Growth Hormone and Recombinant Human Insulin. Biopil will have its own in house Research and Development Laboratory attached to a Common Quality Control, Documentation and Quality Assurance Laboratory.

Agropil is the Agricultural Division of PIL. From a modest start of 3 hectare of green house, it has gradually expanded its floriculture business to 6 hectare of green house and has established its presence in domestic as well as overseas markets. It will be engaged in developing hybrid varieties and genetically modified seeds, bio-fertilizers, bio-pesticides and plant growth stimulants in agriculture

Prouct range of the company include:

Pharma Division

Epo
Docetaxel
Carboplatin
Gefitinib
Rituximab
Oxaliplatin
Cisplatin
Temozolomide
Trastuzimab (Herceptin)
Irnotecan
5-Fluorouracil
Imatinib
Bevacizumab
Epirubicin
Methotrexate
Erlotinib
Cetuximab
Lipo-Doxorubicine,
Tamoxifen

Biotechnology Division

Anti Bacterials â€“ Floroquinolones
Antibiotics â€“ Macrolides
Antibiotics â€“ Betalactums
Antibiotics-Injections/Tab - Betalactum & Cephalospori
Antifungal drugs
Cardiovascular Drugs
Antiulcerants
N.S.A.I.D
Analgesic & Antipyretic
Anti spasmodic
Proteolytic Enzyme
Antihistamines
Neutraceuticals

Agricultural Division

Recently the company grown the different varieties of roses consisting different colours such as red, yellow, pink, white, peach etc. The companys flowers and varieties are known for their quality, stem length, bud size with good foliage, free from any pest and disease.